Activation of ADP-ribosylation factors (ARFs), ϳ20-kDa GTPases that are inactive in the GDP-bound form, depends on guanine nucleotide-exchange proteins (GEPs) to accelerate GTP binding. A novel ARF GEP, designated cytohesin-4, was cloned from a human brain cDNA library. Deduced amino acid sequence of the 47-kDa protein contains the same structural components present in cytohesin -1, -2, and -3, including an ϳ200-amino acid Sec7 domain with an ϳ100-residue pleckstrin homology domain near the C terminus. The Sec7 domain sequence is 77% identical to those of other cytohesins. Structures of the cytohesin-4 and cytohesin-1 genes were remarkably similar, except for an extra 3-base pair (GAG) exon present in cytohesin-1. Two mRNAs with and without the 3-base pair sequence were found in brain in different ratios for cytohesin-1, -2, and -3 but not cytohesin-4. Recombinant cytohesin-4 stimulated guanosine 5-3-O-(thio)triphosphate binding by human ARF1 and ARF5 but not ARF6. Like other cytohesins and unlike the ϳ200-kDa ARF GEPs, it was not inhibited by brefeldin A. A cytohesin-4 mRNA of ϳ3.7 kilobases, abundant in leukocytes, was not detected in most tissues. Among separated populations of blood cells, ϳ90% of CD33 ؉ (monocytes), 80% of CD2 ؉ (NK/T), and 10 -20% of CD19 ؉ (B) cells contained cytohesin-4 mRNA by in situ hybridization. Thus, in gene structure and brefeldin A-insensitive GEP activity, cytohesin-4 resembles other cytohesins, but its tissue distribution differs considerably, consistent with a different specific function.
1 initially identified as activators of cholera toxin-catalyzed ADP-ribosylation, are ϳ20-kDa guanine nucleotide-binding proteins involved in vesicular trafficking pathways, including endoplasmic reticulum and intra-Golgi transport (1, 2) and endocytosis (3) . Effects of ARF on vesicular trafficking may result from its interaction with coatomer (4) and/or activation of phospholipase D (5-7). Mammalian ARFs are grouped into three classes (class I, ARF1, -2, and -3; class II, ARF4 and -5; and class III, ARF6) based on amino acid sequence, size, gene structure, and phylogenetic analysis (8) . ARFs are GTPases that function as molecular switches by alternation between inactive GDP-bound and active GTP-bound states. Inactivation of ARF-GTP requires interaction with a GTPase-activating protein that accelerates hydrolysis of bound GTP (9 -12) . Activation of ARF-GDP depends on the replacement of bound GDP by GTP, which is catalyzed by guanine nucleotide-exchange proteins or GEPs (13) .
Liu and Pohajdak (14) cloned a human cDNA named B2-1 using subtractive hybridization (natural killer cells minus Thelper Jurkat cells); the gene was localized to chromosome 17-qter (15) . The B2-1 gene product cytohesin-1 is a 47-kDa protein found at high levels in natural killer and cytotoxic T-cells and at very low levels in monocytes and several cultured cell lines (16) . Part of its deduced amino acid sequence resembles that of the so-called Sec7 domain of the Saccharomyces cerevisiae Sec7 protein (Sec7p), which had been identified as a pivotal component in Golgi protein transport (17) . Cytohesin-1 was independently isolated in a yeast two-hybrid screen with the intracellular domain of integrin ␤ 2 as a bait and appears to be involved in inside-out signaling via an integrin cytoplasmic domain (16) . Cytohesin-1 contains a central Sec7 domain of ϳ200 amino acids, a coiled-coil domain of ϳ40 amino acids near the N terminus, and an ϳ100-amino acid pleckstrin homology (PH) domain in the C-terminal region. Several proteins with Sec7 domains are now known to possess ARF GEP activity (18 -25) , and GEP activity of the Sec7 domain itself has been demonstrated for several of these (19, 23, 24) . GEP activity of the Sec7 domain of yeast Sec7p was inhibited by brefeldin A (BFA), a fungal fatty acid metabolite that reversibly alters Golgi structure and function, suggesting that the 200-amino acid Sec7 domain contains both the inhibitory and the catalytic sites (24) . The PH domain, by interacting with phospholipids, is believed to be responsible for association of cytohesin with membranes (19) .
Two of the ARF GEPs, designated cytohesin-2 (GenBank TM accession number U70728) or ARNO (19) and cytohesin-3 or ARNO3 (25) or mouse GRP1 (21) , have significant identity with cytohesin-1 in deduced amino acid sequences (ϳ90%). Apparently orthologous rat cDNA sequences (designated msec7-1, -2, and -3) have also been published (26) . To simplify nomencla-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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ture, we refer to this family of proteins as cytohesins, because the cDNA sequence of cytohesin-1 (B2-1) was the first published (14) . The deduced amino acid sequences of ARNO (19) and cytohesin-2 differ only in the presence or absence of a single glycine in the PH domain. Here, we demonstrate the existence of two mRNA isoforms that differ in the same way for each of the three known cytohesins. We describe, in addition, the cDNA and gene structures of cytohesin-4, for which only one mRNA could be detected. To begin to elucidate the regulatory mechanism(s) that control the single glycine insertion/ deletion in the PH domain, we also partially characterized the cytohesin-1 gene. Cytohesin-1 and cytohesin-4, which differ most among the cytohesins, have similar gene structures within the coding region, suggesting that the family may have arisen by gene duplication. Cell Culture and Preparation-Cell lines THP-1, Meg01, MOLT4, KG-1a, ARH-77, Raji, K562, and J774A.1 were purchased from ATCC (Manassas, VA). KG-1a cells were grown in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum, penicillin (50 units/ml), and streptomycin (50 g/ml) at 37°C in 5% CO 2 . All other lines were grown in RPMI 1640 medium supplemented as described for KG-la cells.
EXPERIMENTAL PROCEDURES
Materials-Restriction enzymes and
Buffy coats were collected from heparinized venous blood of healthy donors. Red cells were lysed, and white cells were suspended in phosphate-buffered saline (PBS) and stained with the following cell surface markers: anti-CD15-fluorescein isothiocyanate (FITC), anti-CD33-phycoerythrin (PE), anti-CD2-FITC, anti-CD19-PE, anti-CD4-FITC, anti-CD8-PE (Beckman Coulter, Miami, FL), and anti-CD3-PerCP (Becton Dickinson, San Jose, CA). Cells were sorted on a Beckman Coulter EPICS-ELITE ESP flow cytometer (Beckman Coulter, Miami, FL). Lymphocytes, monocytes, and granulocytes were first defined by size and granularity (forward and side scatter). Additional sort gates based on fluorescent cell surface markers included CD15 ϩ for granulocytes, CD33 ϩ for monocytes, CD2 ϩ for lymphocyte T/NK, and CD19 ϩ for B lymphocytes. T lymphocytes were sorted based on dual positive staining with CD3 ϩ /CD4 ϩ for the helper/inducer subset and with CD3 ϩ /CD8 ϩ for the cytotoxic/suppressor subsets. Purity of each cell population was greater than 98%. Screening of cDNA Library-A human brain frontal cortex cDNA library (ϳ5 ϫ 10 7 plaque-forming units), constructed in Lambda Zap II vector (Stratagene), was screened using a 345-bp DNA fragment (nucleotides 262-606, when ϩ1 ϭ A of the translation initiation codon of B2-1 cDNA) generated by PCR (35 cycles of 94°C/1 min, 45°C/1 min, and 72°C/1 min). The template was 20 ng of cloned B2-1 cDNA, and primers were B2-1-S-1 (5Ј-AAGGATGAGATAGCAGAA-3Ј) and B2-1-AS-1 (5Ј-TCAGTGAACTCATGCAG-3Ј). Samples (50 ng) of the products were labeled using a Random Primer DNA labeling kit (Roche Molecular Biochemicals). After hybridization at 55°C for 16 h in 6ϫ SSC, 20 mM sodium phosphate buffer (pH 8.0), 0.4% SDS, 5ϫ Denhardt's solution containing denatured salmon sperm DNA (100 g/ml) and radiolabeled probe (2 ϫ 10 7 cpm/ml), the final wash was done with 2ϫ SSC, 0.1% SDS at 55°C for 20 min. One of 21 positive clones was identical to ARNO3 (25) .
For subsequent library screening, another 348-bp DNA probe (nucleotides ϩ274 to ϩ621, when A ϭ ϩ1 of the translation initiation codon of ARNO3 cDNA), which includes the Sec7 domain of ARNO3, was generated by PCR amplification (35 cycles of 94°C/1 min, 45°C/1 min, and 72°C/1 min) using 20 ng of the cloned ARNO3 plasmid DNA as template with primers ARNO3-S-1 (5Ј-GACCTGCTACAGAGTTCCCCA-GAAGAC-3Ј) and ARNO3-AS-1 (5Ј-GTTGTGGAGGCTGGT GTTGAG-CAT-3Ј). The product was purified from 1% agarose gel using a QIAEXII Extraction Kit (Qiagen), and a sample (50 ng) was radiolabeled (2 ϫ 10 7 cpm/ml) using a Random Primer DNA labeling kit. The same filters that had been screened with the B2-1 probe were hybridized with the ARNO3 cDNA at 55°C for 16 h with 6ϫ SSC, 20 mM sodium phosphate buffer (pH 8.0), 0.4% SDS, 5ϫ Denhardt's solution containing denatured salmon sperm DNA (100 g/ml), followed by a final wash at 37°C with 2ϫ SSC, 0.1% SDS.
Screening of Human Genomic Library-The human genomic library EMBL-3 SP6/T7 (CLONTECH) was screened using a ϳ1.2-kb DNA fragment including sequence of human cytohesin-1 cDNA (nucleotides ϩ1 to ϩ1194) as radiolabeled probe. Recombinants were grown on agar plates, and replica filters were hybridized with the probe at 42°C for 16 h in a solution containing 50% formamide, 10% dextran sulfate, 1% SDS, 50 mM Tris (pH 8.0), 1 M NaCl. Final washes were at 47°C for 15 min with 0.2ϫ SSC, 0.1% SDS. Cloned phage DNA was digested with EcoRI or EcoRI plus SalI, transferred to a nylon filter, and hybridized with the ϳ1.2-kb cytohesin-1 cDNA. Genomic fragments that hybridized were isolated and subcloned into pBluescript SK(ϩ) for sequencing.
Investigation of Two Isoforms of the PH Domain-DNA fragments that included the codon for the variable single glycine residue in the PH domain were amplified. Cytohesin-1 DNA fragments (282 or 279 bp) were amplified using primers Cyto-1-8-S (5Ј-ATGAACCGAGGCAT-CAATGATGGG-3Ј) and Cyto-1-11-AS (5Ј-TCCCGGATACTCAGAT-TCTCTAAAG-3Ј). Cytohesin-2 DNA fragments (350 or 347 bp) were amplified using primers, Cyto-2-8-S (5Ј-CACAATCCCAATGTCCGG-GACAAGC-3Ј) and Cyto-2-11-AS (5Ј-TCGTCCACCTCTC GGATGCT-CAGAT-3Ј). Cytohesin-3 DNA fragments (370 or 367 bp) were amplified in a nested PCR. The first PCR was performed using primers Cyto-3-8-1-S (5Ј-CGTGCTACGTGC TGTCATTCGCC-3Ј) and Cyto-3-11-1 AS (5Ј-GTTGGGTTTCCGGGGGTCCTCCAC-3Ј). For the second PCR, primers were Cyto-3-8-2-S (5Ј-TGCTCAACACCAGCCTCCACAACCA-3Ј) and Cyto-3-11-2-AS (5Ј-GGGTCCTCCACCTCCCTGATGCTGA-3Ј). All reactions were carried out for 35 cycles of 94°C/1 min, 55°C/1 min, and 72°C/1 min with 2.5 units of Taq DNA polymerase. Products were purified from 1% agarose gel using QIAEX II Gel Extraction Kit followed by phenol/chloroform extraction and ethanol precipitation and subcloned into pCR R TOPOII TA vector (Invitrogen). Positive clones, 45 for each cytohesin gene, were transferred to GeneScreen Plus, followed by allele-specific hybridization with 100 pmol of 5Ј-end radiolabeled oligonucleotide and 500 pmol of unlabeled competitor, Cyto-1ϩG (5Ј-AAACTCGGAGGTGGCAG-3Ј) and Cyto-1ϪG (5Ј-TGAAACTCGGTG-GCAGG-3Ј) for cytohesin-1, Cyto-2ϩG (5Ј-AAGCTGGGAGGGGCCG-3Ј) and Cyto-2ϪG (5Ј-TGAAGCTGGGGGGCCGG-3Ј) for cytohesin-2, and Cyto-3ϩG (5Ј-AAGCTGGGAGGAGGGCG-3Ј) and Cyto-3ϪG (5Ј-GAAGCTGGGAGGGCGTG-3Ј) for cytohesin-3. Final washes were done in 6ϫ SCC, 0.1% SDS at 50°C for 20 min.
Investigation of Exon 2 and Exon 3 Sequences in the Cytohesin-4 cDNA-Based on the similarity of gene structures of cytohesin-1 and cytohesin-4, exon 2 and exon 3 sequences in the cytohesin-4 cDNA were used to synthesize two forward primers for nested PCR, Cyto4EX2-1 (5Ј-AGCCCGCGGACCTGAGCAGCGG-3Ј and Cyto4EX2-2 (5Ј-ACCT-GAGCAGCGGGGAGACGG-3Ј. The first PCR, using Cyto4EX2-1 and Cyto-431 and human leukocyte cDNA as template, was carried out for 35 cycles of 94°C/1 min, 55°C/min, and 72°C/1 min with 2.5 units of Taq DNA polymerase. The same conditions were used for the second PCR with products of the first PCR as templates and primers Cyto4EX2-2 and Cyto-441 to yield E2T (Fig. 1) .
5Ј-Rapid Amplification of cDNA Ends (5Ј-RACE)-To obtain the 5Ј-end of the cDNA, a Human Leukocyte Marathon-Ready cDNA kit (CLONTECH) was used. Two gene-specific primers were synthesized as follows: GSP-1 (5Ј-GTGCAATGTCCTGGACGTCAGG-3Ј) and GSP-2 (5Ј-TGGACGTCAGGGGTCAGCAGCTTG-3Ј). Two adaptor primers for 5Ј-RACE were AP-1 (5Ј-CCATCCTAATACGACTCACTATAGGGC-3Ј) and AP-2 (5Ј-ACTCACTATAGGGCTCGAGCGGC-3Ј). The first PCR using AP-1 and GSP-1 with human leukocyte cDNA as template and 2.5 units of Taq DNA polymerase was carried out for 35 cycles of 94°C/1 min, 55°C/1 min, and 72°C/1 min. The same conditions were used for the second PCR with products of the first PCR (AP-1/GSP-1 PCR products) as template and primers AP-2 and GSP-2. The two different-sized 5Ј-RACE products, ϳ350 (R5F, Fig. 1 ) and ϳ210 bp from the second PCR, were excised from 2% agarose gel, purified by QIAEXII Gel Extraction Kit, subcloned into pCR R TOPOII TA vector by T-A ligation, and sequenced by automated sequencing using M13 reverse primer (5Ј-CAGGAAACAGCTATGAC-3Ј).
Investigation of 5Ј-UTR Sequence of Cytohesin-4 -Because the longest cDNA obtained by 5Ј-RACE, which contained 55 bp upstream of the ATG, lacked an in-frame termination codon, RT-PCR using 1 g of human leukocyte cDNA as template was performed with two sets of nested primers to produce E1ST (Fig. 1) . Primer C4EX1UP-1 (5Ј-CAAG-CAGGAAGGAGCCTGTT-3Ј) and reverse primer Cyto-431 were used for the first PCR, and forward primer C4EX1UP-2 (5Ј-GAAGGAGCCT-GTTACAGTCAAG-3Ј) and reverse primer Cyto-441 for the second.
Each PCR was carried out for 35 cycles of 94°C/1 min, 55°C/1 min, and 72°C/2 min with 2.5 units of Taq DNA polymerase.
Isolation and Expression of Human Cyothesin-4 cDNA-cDNA (ϳ0.3 g) from a blood mononuclear cell fraction was the template for synthesis of full-length human cytohesin-4 cDNA in a nested PCR. Primers C4E1C-1 (5Ј-CCCAGAGGCGTCGGAATGGACCTGTG-3Ј) and C4E13R-1 (5Ј-GTCGACTCACTGCTTGCTGGCAATCTT-3Ј) were used for the first PCR and primers C4E1C-2 (5Ј-GTCGGAATGGACCTGT-GCCACCCAG-3Ј) and 4E13R-2 for the second, with the first PCR product as template. Each PCR was carried out for 35 cycles of 94°C/1 min, 55°C/1 min, and 72°C/2 min using 2.5 units of Pfu DNA polymerase (Stratagene). Products were gel-purified and recovered using QIAEXII Gel Extraction kit. The isolated DNA fragment was incubated for 1 h at 72°C with 4 M dATP and 2.5 units of Taq DNA polymerase before subcloning in pCR R TopoII TA vector. Cytohesin-4 cDNA was amplified by PCR using the forward primer (4C) 5Ј-GACATATGGACCTGTGCCACCCAGAGCCCGCGGAGCTGA-GCAGCGGGGAC-3Ј (italicized sequence is an NdeI cleavage site), reverse primer (TER-1) 5Ј-CTCGAGTCACTGCTTGCTGGCAATCTTCT-TCTT-3Ј (italicized sequence is an XhoI cleavage site), 2.5 units of Pfu DNA polymerase, and 10 ng of plasmid pTA-cytohesin-4 as a template for 30 cycles of 94°C/1 min, 55°C/1 min, and 72°C/3 min. The products were extracted from 1% agarose gel and purified by phenol/chloroform extraction, precipitated with ethanol, and incubated for 1 h at 72°C with 4 M dATP and 2.5 units of Taq DNA polymerase to add a single deoxyadenine, followed by subcloning in pCR R Topo II TA vector. Sequence of the construct was confirmed by automated sequencing using primers Cyto-411, (Cyto-461) 5Ј-CCCAGAAGATAG ACCGGATGAT-3Ј, (Cyto-462) 5Ј-AGGGTTGGCTGCTCAAGCTAG-3Ј, (Cyto-463) 5Ј-CCGA GGAACGTGACCAGTGGA-3Ј, and (Cyto-464) 5Ј-GGGTCAGCAGCTT-GTGCTCAATG-3Ј. Recombinant plasmid in pCR R Topo II TA vector (3 g) was incubated at 37°C for 1 h with NdeI plus XhoI. The purified excised cytohesin-4 fragment was ligated into NdeI/XhoI sites of pET14b expression vector (Novagen).
Preparation of Recombinant His 6 N-terminal Fusion Proteins-For large scale preparation of recombinant protein, 6 ml of overnight culture of the transformed bacteria (BL-21) were added to a flask with 500 ml of LB broth and ampicillin, 100 g/ml, followed by incubation at 37°C with shaking (250 rpm). When the culture reached an A 600 of 0.6, 2 ml of 100 mM isopropyl-␤-D-thiogalactopyranoside were added (final concentration 0.4 mM). After incubation for 3 h, bacteria were harvested by centrifugation (Sorvall Superlite TM GSA, 5500 rpm, 4°C, 10 min) and stored at Ϫ20°C. Bacterial pellets were thawed and dispersed in 10 ml of buffer (20 mM Tris (pH 8.0), 300 mM NaCl) with protease inhibitors (PharMingen), 10 g/ml. Lysozyme (Sigma), 10 mg/ml, was added, and after incubation (4°C, 30 min) cells were disrupted by sonification (Branson Sonifier 450), followed by two cycles of freezing and thawing. The lysate was centrifuged twice (Sorvall Superlite TM GSA, 14000 rpm, 4°C, 20 min). The final supernatant was applied to Ni 2ϩ -His⅐Bind resin (1 ml) that had been equilibrated in buffer (0.5 M NaCl, 20 mM Tris HCl (pH 7.9)) containing 5 mM imidazole. After washing with 6 ml of the same buffer containing 20 mM imidazole, followed by 100 mM imidazole in 50 mM potassium phosphate buffer (pH 6.0) with 10% glycerol, bound proteins were eluted with 400 mM imidazole in the latter buffer. The presence of recombinant protein was verified by SDS-polyacrylamide gel electrophoresis. The His 6 -tagged fusion protein (ϳ50 g/ml) was divided into small portions and stored at Ϫ20°C. Two different preparations of each protein were used for the experiments reported here.
Assay of GEP Activity-Assay of GEP activity (27) was based on the stimulation of [
35 S]GTP␥S binding to recombinant human ARF1 (28), ARF5 (29) , or ARF6 (30) as well as partially purified (31) bovine ARFs (chiefly ARF1 and ARF3). Bovine ARF1 is 100% identical in deduced amino acid sequence to human ARF1. Briefly, ARF was incubated with or without GEP at 30°C for the indicated time in buffer containing 20 mM Tris-HCl (pH 8.0), 1 mM NaN 3 , 10 mM dithiothreitol, 3 mM MgCl 2 , 0.2 mM EDTA, 20 -30 mM NaCl, 280 mM phosphatidylserine, 100 g of bovine serum albumin, and 4 M [ 35 S]GTP␥S (total volume, 100 l). Protein-bound nucleotide was collected on nitrocellulose for radioassay (31) . All assays were carried out in triplicate, and experiments were repeated at least twice with different preparations of recombinant proteins.
mRNA Blot and in Situ Hybridization-PCR-generated 595-bp cytohesin-4 DNA (50 ng) that included Sec7 domain codons plus adjacent 5Ј sequence was labeled with [␣-32 P]dATP (3000 Ci/ml) using a Random Primer labeling kit, and purified with a Quick Spin column (Amersham Pharmacia Biotech). Human multiple tissue Northern blots (CLON-TECH) were hybridized in a solution containing 50% formamide, 10% dextran sulfate, 1% SDS, 50 mM Tris (pH 8.0), 1 M NaCl at 42°C for 16 h before final washing with 0.2ϫ SSC, 0.1% SDS at 47°C for 15 min. The same conditions were used for hybridization with samples (20 g) of total RNA from cultured leukocyte-derived cell lines (1 ϫ 10 7 cells) that had been subjected to electrophoresis in a 6.5% formaldehyde, 1.2% agarose gel and transferred to GeneScreen Plus (NEN Life Science Products).
Cellular Localization of Cytohesin-4 mRNA-Total mononuclear cell RNA was extracted from 20 ml of blood from a normal volunteer using Trizol solution (Life Technologies, Inc.), and 5 g was used for cDNA transcription with 200 units of Superscript II RT and 150 ng of random hexamers (Life Technologies, Inc.). Based on the assumption that illegitimate (ectopic) transcription of the cytohesin-4 gene may occur in every cell type (32), a 595-bp cytohesin-4 cDNA fragment (ϩ189 to ϩ784) was amplified using 2.5 units of Taq DNA polymerase and two sets of primers for nested PCR. Primers for the first PCR were Cyto-411 in exon 4 (5Ј-CCGGATGGCCCAGAAGGAGAAGG-3Ј) and Cyto-431 in exon 9 (5Ј-CTAGCTTGAGCAGCCAACCCTCCC-3Ј). Primers Cyto-421 (5Ј-GAGCTGTGT ATTGGGCGCAAGAAGT-3Ј) and Cyto-441(5Ј-GGTC-TGGATTGAAGAAGGTGTGAGTG-3Ј) were used for the second PCR. Both were carried out for 35 cycles of 94°C/1 min, 55°C/1 min, and 72°C/1 min. The resulting products were purified from 1% agarose gel using QIAEX II Gel Extraction Kit followed by phenol/chloroform extraction and ethanol precipitation, subcloning into pCR R TOPOII TA vector, and sequencing.
For in situ hybridizations, a 350-bp fragment of cytohesin-4 mRNA corresponding to nucleotides 143-492 (ϩ1 ϭ A of translation initiation codon) was amplified by PCR using 50 pmol each of forward (cRNA/F) 5Ј-CTGCTTCGAGAGTGCGGAGG-3Ј and reverse (cRNA/R) 5Ј-CCAT-CATCCGGTCTATCTTC-3Ј primers with 2.5 units of Pfu DNA polymerase and 250 ng of plasmid pTA-cytohesin-4 as template for 30 cycles of 94°C/1 min, 55°C/1 min, and 72°C/2 min and cloned into pBluescript KS ϩ plasmid (Stratagene, La Jolla, CA). Sense and antisense riboprobes were generated from a linearized pBluescript plasmid containing the 350-bp fragment using T3 (antisense) or T7 (sense) RNA polymerase and biotin-16-UTP (Roche Molecular Biochemicals).
In situ hybridizations were performed essentially as described previously (33) . Briefly, cells stained with monoclonal antibodies and sorted by flow cytometry were adhered to slides by cytospin, air-dried, and stored at Ϫ80°C. Before hybridization, cells were fixed (30 min), in 4% paraformaldehyde/PBS, washed three times with PBS, and permeabilized for 10 min in 0.25% acetic acid, 0.1 M triethanolamine, followed by washing three times with PBS (all at room temperature). Specimens were dehydrated in increasing concentrations of ethanol and air-dried. Prehybridization was performed at 50°C for 2 h in a moist chamber with 50 l of hybridization solution (Ambion, Austin, TX). After hybridization at 50°C for 16 h in 50 l of hybridization solution containing 5 ng of biotinylated antisense (or sense) RNA probe, cells were washed twice for 4 min with 2ϫ washing solution and finally twice for 4 min with 1ϫ washing solution. For fluorescence detection of the hybridized probe, cells were incubated with 1.0 l (1 g) of FITC-conjugated streptavidin (Vector Laboratories, Burlingame, CA) in 100 l of PBS. After washing three times with PBS, specimens were mounted with Vectashield with propidium iodide (Vector Laboratories) for inspection and photography with a confocal scanning microscope (Leica model TCS4D/DMIRBE).
RESULTS
Cloning of Cytohesin-4 cDNA by Phage Library Screening-
The 1750-bp partial cDNA for a novel member of the cytohesin family, cytohesin-4, was isolated from a human frontal cortex cDNA library using 348 bp of human ARNO3 cDNA as probe and low stringency hybridization conditions. Identical sequence, "dJ63G5.1" in GenBank TM (accession number Z94160), was derived from PAC 63G5 on chromosome 22q12.3-13.1 and is similar to human cytohesin-1. The human cytohesin-1 gene was characterized to enable us to search GenBank TM for cytohesin-4 sequences.
Isolation of the Human Cytohesin-1 Genomic ClonesScreening a human genomic library (3 ϫ 10 5 plaque-forming units) with a 32 P-labeled ϳ1.2-kb human cytohesin-1 cDNA yielded four overlapping phage clones (R7, C38, C13, and C30 in Fig. 2 ), which covered ϳ40 kb including part of intron 1 and ϳ2.5 kb of 3Ј-noncoding region (Fig. 2) . Compared with the human cytohesin-1 cDNA sequence, the isolated clones were lacking 91 bp at the 5Ј-end, representing 69 bp of 5Ј-UTR and
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22 bp of coding sequence. Several attempts to isolate genomic fragments containing this sequence by hybridization using a 47-bp 32 P-labeled probe (5Ј-GAGCGCGGAGCCCGGCTCCCG-CACCATGGAGGAGGACGACAG CTACG-3Ј) were unsuccessful, probably due to the high GC content of the oligonucleotide.
Isolation of Full-length Cytohesin-4 cDNA-The GenBank TM sequence dJ63G5.1 contains 10 potential exonic sequences from exon 4 to exon 13 ( Fig. 2) . To confirm that these potential exonic sequences are expressed as a mRNA and do not represent a pseudogene, nested PCR with 1 g of human leukocyte cDNA as template was performed using sense primers Cyto-411 and Cyto-421 and antisense primers Cyto-431 and Cyto-441. Sequences of resulting products completely matched these potential exonic sequences. The size of each coding exon was the same as that in the human cytohesin-1 gene, except that the 3-bp exon 10 in the human cytohesin-1 gene was missing in the cytohesin-4 PCR product. Based on the similarity of amino acid sequences, the sizes of exonic sequences, and exon-intron boundary consensus sequences, sequences corresponding to exons 2 and 3 of human cytohesin-1 were found among data bank nucleotide sequences (GenBank TM accession number Z94160) ( Fig. 1 and Fig. 2 ). To confirm that the two potential sequences were included in cytohesin-4 mRNA, nested PCR was performed using sense primers cyto4EX2-1 (5Ј-AGCCCGCGGACCTGAGCAG CGG-3Ј) and cyto4EX2-2 (5Ј-ACCTGAGCAGCGGGGAGACGG-3Ј) and reverse primers Cyto-431 and Cyto-441 with human leukocyte cDNA as template. Because the PCR product E2T was of the expected size and sequence (Fig. 1) , we concluded that potential exons 2 and 3 were present in cytohesin-4 mRNA.
The full-length 1390-bp cytohesin-4 cDNA, which contains an open reading frame of 1182 bp encoding 394 amino acids, 5Ј-untranslated region, and 3Ј-noncoding region, was constructed by combining information from structural analogy with the human cytohesin-1 gene and 5Ј-RACE procedures (Fig. 1) . The shorter 5Ј-RACE product (ϳ210 bp) was the cytohesin-4 cDNA that contained exons 2-4. The context of the postulated initiation codon ATG (GTCGGAATGGAC) is not a Kozak consensus sequence (34) . The longest cDNA product of 5Ј-RACE (R5F) contained 55 bp upstream of the ATG. Sequencing a product of RT-PCR (E1ST) identified an in-frame termination codon (TGA) 87 bp upstream of the initiation codon (ATG). In the 3Ј-UTR, there are two polyadenylation signals (AATAAA), 1817 and 2709 bp downstream from the termination codon (TGA). The clone (F2B, Fig. 1 ) isolated by phage screening, however, contained neither a poly(A) ϩ tail nor polyadenylation signal.
The encoded protein is predicted to have a molecular mass of 47 kDa with an amino acid sequence that is 77% identical to that of cytohesin-1 in the Sec7 domain and 69% overall (Table  I) . Cytohesin-4 is the most divergent of the cytohesin family, both in overall sequence and sequence within the catalytic Sec7 domain. The alignment of coiled-coil, Sec7, and pleckstrin homology (PH) domains in cytohesin-4 and the other cytohesins are the same (Fig. 3) , and the degree of identity in PH domains parallels that in the Sec7 domains, as does that of the coiledcoil domains, which are the least similar (Table II) . A major difference between the amino acid sequence of cytohesin-4 and those of other cytohesins is the absence of a glycine in the hinge region (variable loop) between the first and second ␤ sheets of the PH domain in cytohesin-4 (Fig. 4) . Allele-specific hybridization followed by PCR and subcloning of the products revealed that the "extra" GAG sequence was present in 80% of adult brain cytohesin-1 mRNA. Similar results (ϳ90% of brain mRNA) were obtained for cytohesin-2 (ARNO). Only 20% of brain cytohesin-3 mRNA, however, contained the GAG sequence (Table III) . Sequencing of the RT-PCR product revealed no corresponding GAG sequence in the cytohesin-4 cDNA, which would result in the absence of a glycine in the PH domain, although the corresponding sequence (5Ј-AGGAGGT-3Ј) is present in the cytohesin-4 gene.
Comparison of Organization of Human Cytohesin-1 and Cytohesin-4
Genes-Partial characterization of the cytohesin-1 gene identified at least 14 exons. Genomic fragments containing the presumed exon 1 of cytohesin-1, which would include 69 bp of noncoding and 22 bp of coding sequence, were not found. The organization of cytohesin-4 and cytohesin-1 genes is the same in number and size of exons as well as amino acid sequence encoded in each exon, except that the cytohesin-1 gene appears to have an extra 3-bp (GAG) exon in the region encoding the PH domain. Sequences of intron/exon boundaries in the two genes are shown in Tables IV and V. Sizes of introns in the cytohesin-4 gene range from 392 bp to over 10 kbp and in the cytohesin-1 gene from 450 bp to over 15 kbp. Exons encoding the Sec7 domain (exons 4 to 9) in the cytohesin-1 gene are located within 5 kb and seem to be clustered, whereas exons encoding the Sec7 domain of cytohesin-4 are spread over 13 kbp. All introns in both genes begin with GT and end with AG, consistent with the donor/acceptor splice rule.
Effect of Cytohesin-4 on [ 35 S]GTP␥S Binding by rARFs -1, -5, and -6 -Initial rates of [
35 S]GTP␥S binding to rARF1 were increased to similar extents by cytohesin-1 and cytohesin-4 (Fig. 5) . Cytohesin-4 may have been slightly less effective than cytohesin-1 with rARF5 but with rARF6 was, if anything, inhibitory (Fig. 6) .
At concentrations up to 360 M (ϳ10 g per assay), BFA E1ST is a PCR-amplified product obtained using primer EX1UP-1 from 206 bp upstream of initiation codon (ATG) and primer 431. E1T is a PCR product containing the full coding sequence. * indicates the amino acid number.
failed to inhibit the Ͼ20-fold stimulation of GTP␥S binding to native ARF induced by cytohesin-1 or cytohesin-4 ( Fig. 7 and data not shown). Effects of the same BFA concentrations on the activity of a BFA-sensitive mutant of p200 (38) are shown as a positive control.
Distribution of Cytohesin-4 mRNA among Cell Populations-On multiple human tissue Northern blot filters (CLON-TECH), a major band of ϳ3.7 kb that hybridized with a cytohesin-4 cDNA probe was found predominantly in human peripheral blood leukocytes. The same size mRNA was much less abundant in spleen and thymus and was not detected in other tissues (Fig. 8, a and b) . Trace amounts of hybridization corresponding to nucleotides of ϳ5, ϳ6.5, ϳ9 and ϳ12 kb were detected in leukocytes after exposure of film for 3 days (Fig. 8,  a and b) . Similar analysis of poly(A) ϩ RNA (2 g) prepared from human peripheral blood leukocytes and bone marrow revealed no hybridizing RNA in the latter (data not shown).
In cultured leukocyte-derived lines, cytohesin-4 mRNA was prominent in THP-1 (human monocyte-macrophage) and J774A.1 (mouse macrophage) cells, less abundant in KG-1a (CD34 ϩ chronic myelogenous leukemia) and ARH-77 (B-cell lymphoma) cells, and essentially undetectable in the other four cell lines (Fig. 8c) . Cytohesin-1 mRNA of a similar size was, however, seen in all of the cell lines (Fig. 8c) .
Cytohesin-4 mRNA in populations of cells separated from human peripheral blood by flow cytometry sorting was evaluated by in situ hybridization using a 350-bp fragment of cytohesin-4 cDNA (Fig. 9) . Initial experiments revealed that Ͼ90% of CD33 ϩ cells (mostly monocytes) and ϳ80% of CD2 ϩ cells (T/NK) were positive, whereas no cytohesin-4 mRNA was detected in CD15
ϩ cells (granulocytes) and only 10 -20% of CD19 ϩ cells (B) were positive. Because CD2 ϩ cell preparations contained NK as well as CD3 ϩ T-cells, subpopulations of CD3 ϩ / CD4 ϩ and CD3 ϩ /CD8 ϩ cells were investigated. Among both types of T-cells, ϳ80% contained abundant cytohesin-4 mRNA. Representative fields of cells from each of these six populations after hybridization with specific antisense and sense cytohesin-4 cDNAs are shown in Fig. 9 .
DISCUSSION
A novel ARF GEP cDNA was cloned from a human frontal cerebral cortex library, and further characterized utilizing 5Ј-RACE, human genomic sequence obtained from the GenBank TM data base (accession number Z94160), and our new data regarding the cytohesin-1 gene structure. GEP activity of the protein product was demonstrated, and it was designated cytohesin-4, based on the similarity of its activity and overall protein structure to those of the other known cytohesins. The molecule contains an N-terminal coiled-coil domain of ϳ40 amino acids, possibly involved in dimerization, a central Sec7 domain of ϳ200 amino acids, which in other ARF GEPs is the region responsible for guanine nucleotide-exchange activity (19, 20, 23, 24) , and a C-terminal PH domain that mediates phospholipid (PtdIns4,5P 2 or PtdIns3,4,5P 3 ) stimulation of GEP activity (19 -21) as well as, presumably, membrane association (19) . The amino acid sequence of the Sec7 domain of cytohesin-4 is ϳ77% identical to those of cytohesins-1, -2, and -3, which are more than 86% identical to each other (Table I) . Co-crystallization of recombinant ARF1 lacking the first 17 residues and the Sec7 domain of ARNO (cytohesin-2) had revealed two sites of interaction (35, 36) . The amino acid sequences of these regions are identical in the cytohesin-4 Sec7 domain, as well as in those of cytohesin-1 and -3, consistent with functional evidence that cytohesin-4 is an ARF GEP. 64  50  61  p200  47  51  47  50  95  70  46  59  p190  46  51  47  50  90  67  46  58  ySec7  44  46  46  44  47  46  54  58  Gea1  32  33  32  32  30  30  34  48  EMB30  42  45  42  45  41  40  42  34 * In parentheses, percentages for complete proteins are given.
Cytohesin-1 and -4 Function and Gene Structure
Cytohesin-4 mRNA was present predominantly in peripheral blood leukocytes and not in bone marrow cells, whereas cytohesin-1 and cytohesin-2 mRNAs were seemingly more broadly distributed (16) , and mRNAs for the rat cytohesin homologues (msec7-1, -2, and -3) were present in all tissues (26) . Because of the apparently more restricted expression of cytohesin-4, we attempted to identify the specific cells in which it was present, to gain some clue to a function that might differ from those of the more widely distributed cytohesins. Cytohesin-1, albeit expressed in many tissues that apparently lack cytohesin-4, was first cloned as an mRNA present in NK cells but not in helper T-cells (14) . Although cytohesin-4 mRNA was abundant in both
CD3
ϩ /CD4 ϩ (helper) and CD3 ϩ /CD8 ϩ (cytotoxic) T-cells, its presence in NK cells remains to be determined.
Most CD33 ϩ cells (largely monocytes), 80% of CD2 ϩ cells (NK, helper, and cytotoxic T-cells), and 10 -20% of CD19 ϩ cells (B-cells) also contained cytohesin-4 mRNA, whereas CD15 ϩ cells (mostly granulocytes) did not. Cultured THP-1 cells (human monocyte-macrophage line) and J774A.1 cells (mouse macrophage line) also contained cytohesin-4 mRNA. These two cell lines share the ability to function as phagocytes and as antigen-presenting cells. Cytohesin-4 mRNA was not detected in cultured Molt-4 cells (human T-cell lines), which are blocked at an immature stage, although it was found in KG-la (CD34 ϩ ) cells. It appears that cytohesin-4 is expressed in the more mature cells of T-cell and myelomonocytic lineages (and some B-cells).
Cytohesin-4 exhibited GEP activity in vitro with both ARF1 (class I) and ARF5 (class II) but was inactive with ARF6 (class III). This substrate specificity is similar to that of cytohesin-1 (23) and cytohesin-3 (20) . ARNO (cytohesin-2) was reported to a Sequences of ARNO and ARNO3 are GAG-negative.
Cytohesin-1 and -4 Function and Gene Structure
be active with ARF6 at lower Mg 2ϩ concentrations, albeit seemingly inactive at a "physiological" Mg 2ϩ concentration (37) . Like other cytohesins, cytohesin-4 was not inhibited by brefeldin A, which inhibits the activity of the ϳ200-kDa ARF GEPs (24, 38) .
The coiled-coil and PH domains of cytohesin-4, like the Sec7 domain, are less similar in sequence to those of the other three cytohesins than the latter are to each other (Table II) , suggesting that cytohesin-4 may be representative of a previously unrecognized subfamily of cytohesins. The cytohesin-1 and cytohesin-4 gene structures are, however, very similar, consistent with their having arisen through gene duplication. The par- 
tially characterized cytohesin-1 gene contains at least 14 exons, although sequence corresponding to exon 1 of cytohesin-1 cDNA was not found in any of the initially isolated phage genomic clones. Based on our knowledge of the structure of cytohesin-1, the N-terminal amino acid sequence of cytohesin-4 was deduced from sequence dJ63G5.1 (GenBank TM accession number Z94160) in the GenBank TM data base. The sizes of exons 2-9 and 11-14 of the cytohesin-1 gene are identical to those of exons 2-9 and 10 -13, respectively, of the cytohesin-4 gene. Cytohesin-1, however, appears to have an extra exon of only 3 bp (GAG) that results in the insertion of a single glycine (Fig. 4) in the variable loop between the first and second ␤-sheets of the PH domain (39 -42) . Comparison of cDNA sequences of cytohesin-1, -2, and -3 led us to conclude that the single glycine insertion in each might be regulated by an alternative splicing mechanism.
In human brain, the mRNAs for cytohesin-1 and -2 were 80 -90% GAG-positive, whereas only 20 -30% of cytohesin-3 mRNA contained the GAG (Table III) . There were no major differences between fetal and adult human brain in percentages of the two isoforms of cytohesin-2 or -3 (Table III) . The significance of the small difference in ratios of the two isoforms of cytohesin-1 in adult and fetal brain remains to be established, although it may well reflect developmental influences. No extra sequence (GAG) was found in cytohesin-4 cDNA, although the sequence 5Ј-AGGAGGT-3Ј is present in intron 9 of the gene. Because the size of an intron between this potential extra GAG and exon 10 would be only 54 bp, it might be difficult to generate the structure needed for splicing of the cytohesin-4 transcript to produce an mRNA containing the GAG exon. In the cytohesin-1 gene, the 2.3 kb of intron 9 and 2.2 kb of intron 10 perhaps make it easier to achieve a structure that facilitates splicing.
The effects of the extra glycine in the cytohesin PH domains on function, although not yet determined, seem likely to be significant. The functional consequences of specific amino acid replacements in the first variable loop of PH domains in other proteins are well known, including the replacement of Arg-28 with Cys in this region of Bruton's tyrosine kinase, which in mice results in X-linked immunodeficiency. This mutation does not affect the kinase activity but interferes drastically with B-cell activation, consistent with a critical role for the PH domain in interactions with signaling molecules (43, 44) . Three-dimensional structures of PH domains from several different proteins are known to be similar, with seven ␤-strands connected by three variable loops that are arranged together to form a positively charged molecular surface (39 -41) , which suggested interaction with negatively charged ligands. Prominent among these are inositol phospholipids and inositol phosphates (reviewed briefly in Ref. 45 ). Phosphoinositides, including products of phosphoinositide 3-kinases (PI3K) that are components of several kinds of signaling pathways, stimulate cytohesin GEP activity (18 -21) . Mouse cytohesin-3 (GRP1) was, in fact, identified in a two-hybrid screen for proteins that bound phosphatidylinositol 3,4,5-trisphosphate (PtdIns3, 4,5P 3 ) with high affinity (21) . Klarlund et al. (20) directly compared the affinity of the cytohesin-3 PH domain for PtdIns3,4,5P 3 with those for other phosphoinositides and demonstrated inhibition by inositol 1,3,4,5-tetraphosphate of PtdIns3,4,5P 3 stimulation of cytohesin-3 GEP activity. They also showed that specificity of the phosphoinositide effect on GEP activity was markedly influenced by the charge density of phosphatidylcholine micelles ϩ RNA from the indicated tissues was hybridized with a 595-bp cytohesin-4 cDNA followed by exposure of film for 1 day (a) or 3 days (b). After stripping, the blot was hybridized with GAPDH cDNA followed by exposure of film for 6 h (b, inset). c, samples (20 g) of total RNA from each cell line were subjected to electrophoresis in a 6.5% formaldehyde, 1.2% agarose gel and transferred to GeneScreen Plus (NEN Life Science Products). The blot was hybridized successively as described under "Experimental Procedures" with cDNA probes for cytohesin-4, cytohesin-1, and GAPDH. Each probe was removed by washing in 0.1% SDS, 0.1ϫ SSC after exposure to film for 1 day. GAPDH film was exposed for 6 h. Lanes are as follows: 1st, THP-1; 2nd, Meg01; 3rd, Molt4; 4th, KG-1a; 5th, ARH-77; 6th, K562; 7th, Rajii; and 8th, J774A.1. All lines except J774A.1 were established from leukemia cells. used in the assay. Rather small changes in detergent composition resulted in no activation by any of the phosphoinositides or in essentially equal stimulation by PtdIns3,4,5P 3 and PtdIns4,5P 2 or PtdIns3,4P 2 (20) . This is a dramatic reminder of the difficulty of knowing which observations of activity or function of ARFs and ARF GEPs reflect accurately the intracellular process.
PH domains have several types of ligands, protein as well as phospholipid. Because the positively charged surface of these domains can be so variable in structure, it was suggested to be particularly suitable for establishing binding specificity (43) . Artalejo et al. (42) demonstrated that Gly-24 and Ile-25 in the first variable loop of the dynamin-1 PH domain are required for its function in rapid endocytosis by chromaffin cells. The presence (or absence) of a single glycine in the first variable loop of a cytohesin PH domain seems likely to make an important difference in its function, although probably not in the catalytic GEP activity, since removal of the PH domain from cytohesin-2 (ARNO) abolished activation by PtdIns4,5P 2 but not GEP activity (19) . The single glycine difference might modify the action of cytohesin-1 in an integrin signaling pathway (16), for example, or in other cytohesin interactions not yet recognized. Differences among cytohesins in the relative amounts of mRNAs with and without the extra GAG in human brain (and perhaps a difference between percentages of the two isoforms of cytohesin-1 mRNA in adult and fetal brain) are consistent with regulation of alternative splicing and distinct activities of the two protein products.
It is notable that the degree of identity among cytohesin PH domains is as high as that among their Sec7 domains, surely reflecting functional importance, whether or not directly related to the integration and regulation of ARF action. Overexpression of a cytohesin-1 PH domain fusion protein in cultured Jurkat cells interfered with T-cell receptor-stimulated adhesion, whereas overexpression of an intact cytohesin or Sec7 domain fusion protein resulted in constitutive adhesion (16) . These effects apparently have never been experimentally related to the action of cytohesin-1 as an ARF GEP, although a model for a signaling pathway from tyrosine kinase receptors via PI3K and cytohesin to ARF activation and/or integrin ␤2 regulation has been proposed (21) . Overall, cytohesin-4 presents characteristics similar to those of other cytohesins in protein structure, gene organization, substrate specificity, and BFA insensitivity. In tissue distribution, however, it appears to be restricted to a population of peripheral blood lymphocytes in which it may have a specific, as yet unidentified, biological function. In addition, it does not apparently share one potential regulatory mechanism of alternative mRNA splicing, which produces isoforms of other cytohesin proteins. These isoforms differ only in the presence of a single glycine in the first variable loop of the PH domain, a functionally critical region in several other proteins. It will be important to learn the effects of cytokines and other inflammatory mediators on this as well as other aspects of cytohesin-4 expression and activity.
Cytohesin-4 is to be added to the growing list of known ARF GEPs, which already outnumber their mammalian ARF substrates. These numerous proteins with their multidomain structures surely have important functions in addition to their GEP activity and critical interactions with molecules other than ARF and phospholipids. It is easy to envision a specific GEP participating as an anchoring component in a supramolecular complex that ensures activation of the correct ARF as needed for its action in a trafficking or signaling pathway. Definition of the details of this process will require considerably more work. ϩ /CD8 ϩ cells. In situ hybridization was performed using 350-base biotinylated antisense and sense cRNA probes for cytohesin-4 and detected by FITC-conjugated streptavidin (green). Nuclei were stained with propidium iodide (red). The antisense probe used for each frame is identified. The adjacent unlabeled frame to its right shows cells hybridized with the corresponding sense probe.
